findmyKOL
Clinical trialNCT05048238CompletedPhase 1Interventional

Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment7Cutaneous Lupus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a single-arm, multi-site, proof-of-concept study that will evaluate the treatment of 10 participants with cutaneous lupus erythematosus (CLE) with Tofacitinib.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Massachusetts Medical School

    Worcester, Massachusetts, United States

  • University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology

    Ann Arbor, Michigan, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2022
Primary completion
15 Feb 2024
Completion
29 Feb 2024
Last update posted
22 Aug 2025
Registered enrollment
7
Registry id
NCT05048238

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.